Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s40801-024-00476-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction: Falls and Fractures Among Nursing Home Residents Treated with Pimavanserin Versus Other Atypical Antipsychotics: Analysis of Medicare Beneficiaries with Parkinson's Disease Psychosis.
Drugs Real World Outcomes
January 2025
Medical Affairs, Acadia Pharmaceuticals Inc, San Diego, CA, USA.
Correction: Fear of falling and its related factors in older adults following a fall in Kashan, Iran (2023-2024).
BMC Geriatr
January 2025
Student Research Committee, Kashan University of Medical Sciences, Kashan, Iran.
Incorporation of RLINE into AERMOD: An update and evaluation for mobile source applications.
J Air Waste Manag Assoc
January 2025
ICF International, San Francisco, California.
The R-LINE model, which was released in 2013 as a stand-alone model for roadway-type applications and was based on a set of newly developed dispersion curves, exhibited favorable model performance in a limited set of evaluations (Heist et. al, 2013, Snyder et al. 2013, Venkatram et al.
View Article and Find Full Text PDFThe Political Sociology of NICE: Investigating Pharmaceutical Cost-Effectiveness Regulation in the UK.
Sociol Health Illn
January 2025
Department of Global Health and Social Medicine, King's College London, London, UK.
The National Institute for Health and Care Excellence (NICE) was established a quarter of a century ago in 1999 to regulate the cost-effectiveness of pharmaceuticals (and other health technologies) for the NHS. Drawing on medical sociology theories of corporate bias, neoliberalism, pluralism/polycentricity and regulatory capture, the purpose of this article is to examine the applicability of those theories to NICE as a key regulatory agency in the UK health system. Based on approximately 7 years of documentary research, interviews with expert informants and observations of NICE-related meetings, this paper focuses particularly on NICE's relationship with the interests of the pharmaceutical industry compared with other stakeholder interests at the meso-organisational level.
View Article and Find Full Text PDFAfrica and Arabia encompass a much greater species diversity in the aggregate (Amaranthaceae, achyranthoid clade): Evidence from morphological and chorological data.
PhytoKeys
December 2024
The Mauritius Herbarium, RE Vaughan Building, Agricultural Services, Ministry of Agro-Industry and Food Security, Réduit, 80835, Mauritius.
in its traditional sense (excluding that phylogenetically falls into ) has been considered to contain a restricted (three to four) number of species in Africa and one or two species in the Arabian Peninsula. The morphology of the type species of the genus, , has been treated as highly polymorphic, with several varieties recognised by various authors. Not surprisingly, a recent extended phylogeny revealed a non-monophyly of .
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!